Marina De Smet

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Gary Herman, Arthur Bergman, Catherine Stevens et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 498 citations

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

Arthur Bergman, Catherine Stevens, Yanyan Zhou et al. · Clinical Therapeutics · 2006 · 265 citations

Pharmacological Study, Medicine, Healthy Male Volunteers +5

The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo

Zuzana Diamant, Mieke Timmers, H. van der Veen et al. · Journal of Allergy and Clinical Immunology · 1995 · 157 citations

Inflammation, Asthma, Protein Inhibitor +10

Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869

Simon Van Belle, M. Lichinitser, Rudolph M. Navari et al. · Cancer · 2002 · 147 citations · Full text

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

Haiyung Cheng, Jonathan A. Leff, Raju D. Amin et al. · Pharmaceutical Research · 1996 · 139 citations